CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

April 28, 2022 · earnings

CBIO earnings: a negative outcome, -8.0%

On April 28, 2022, CRESCENT BIOPHARMA, INC. reached its earnings. The result was a negative outcome, and the stock moved -8.0% in the window around the event. It had already run -22.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$84.01
1d before
$77.31
Event day
$71.86
1d after
$72.90
5d after

Pre-catalyst setup

-22.8%
30-day run-up
3734%
30-day volatility
0.8×
volume spike